Advertisements

Йодинол

Quick links to important sections

Йодинол

Advertisements
Advertisements

Treatment option: Tonsillitis

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Йодинол

Overview: What is Йодинол?

Here is a quick summary of the medicine's fundamental properties:

Property Description
Active Ingredient Elemental Iodine
Form Solution for local/topical use
Pharmacological Class Antiseptic
Common Use Local surface cleansing and hygiene
Origin Synthetic Chemical Complex

What Type of Medicine is Йодинол?

Йодинол (Iodinol) is an established antiseptic solution used for local and topical application, distinguished by its unique composition where elemental iodine is chemically complexed with polyvinyl alcohol. This compound is broadly classified within the pharmacological class of antiseptics and disinfectants. As a manufactured preparation combining chemical components, it is considered a synthetic chemical complex.

The use of iodine-based compounds in topical preparations is characterized by the efficacy of iodine complexes as broad-spectrum antimicrobial agents. The medicine helps fight a wide variety of germs, including bacteria and fungi, on the surface of the body.


What is Йодинол's Unique Composition?

Йодинол is typically provided as a dark liquid or solution for external use; its core ingredients are elemental iodine and a polymer base, specifically polyvinyl alcohol (PVA), dissolved in water. The PVA acts as a stabilizing carrier, binding the highly active iodine to form a complex. This binding mechanism is key to the solution's action, as the complex is intended to facilitate a controlled and gradual release of the iodine onto the application area. By slowing down the release of the active agent, the composition is thought to provide a more prolonged effect while being less harsh on tissues than pure iodine solutions.


General Purpose: What Does It Do?

The general purpose of Йодинол is to provide a local germ-fighting action to support the body's defenses by controlling the presence of unwanted microorganisms. This medicine works through the powerful oxidizing principle of iodine, which rapidly disrupts the structure of microbial cells right on the applied surface. The overall goal is to maintain an optimal, clean environment on the skin or mucous membranes. This cleansing effect helps to soothe and manage minor local surface irritations by reducing the microbial load in the area.

Regulatory References

  1. NIH Antiseptics Review
Advertisements

What side effects are possible with Йодинол?

Possible Side Effects and Safety Information

The official safety profile for this topical antiseptic is structured around local application effects and the systemic risk associated with iodine absorption, based on authoritative regulatory documentation for iodine complexes.


Adverse Reaction Scope

The most commonly documented adverse reactions are local and dermatological, falling under Skin and Subcutaneous Tissue Disorders. These effects include irritation, redness (erythema), or a burning sensation at the application site.

Classification System-Organ Class Involved
Rare Immune System Disorders (Hypersensitivity)
Rare Endocrine System Disorders (Thyroid)

Serious adverse reactions, classified as Very Rare or reported in isolated cases, include severe systemic reactions such as Anaphylactic Shock. The systemic uptake of iodine can also lead to Iodine-Induced Hyperthyroidism, particularly in susceptible individuals. Acute impairment of kidney function (Renal and Urinary Disorders) has been documented following the absorption of large amounts of iodine, such as after application to extensive burns.


Safety Constraints and Considerations

The risk of systemic adverse reactions is directly associated with the Duration and Extent of Exposure. Prolonged use or application to large areas of compromised skin significantly increases the absorption of iodine, thereby raising the potential for systemic effects.

Regulatory documents include safety notes for specific populations and conditions:

  • Pre-existing Thyroid Disease: Individuals with conditions like goiter are at an increased risk of developing thyroid hyperfunction.
  • Newborns and Infants: This population is noted to be at an increased risk of developing hypothyroidism from iodine uptake.

Safety restrictions prohibit use in individuals with known iodine hypersensitivity, established hyperthyroidism, and prior to or following radioactive iodine therapy. The product is also restricted from concomitant use with certain mercury-containing preparations.

Advertisements

Overdose and Emergency Response

Overdose from iodine solutions, such as Йодинол, is a serious risk most often associated with accidental ingestion of large quantities or extensive systemic absorption from large, compromised skin areas like severe burns. Officially documented acute overdose presentations include severe gastrointestinal corrosive effects characterized by intense burning pain in the mouth and throat, salivation, vomiting, and bloody diarrhea. Systemic toxicity may also cause fever, tremors, and a decreased level of alertness, potentially progressing to stupor or confusion.

The regulatory profile highlights life-threatening outcomes affecting major systems, including circulatory collapse (shock), acute renal failure (anuria), and laryngeal edema leading to respiratory distress. Immediate medical help must be sought or emergency services contacted when an overdose is suspected, especially if these severe symptoms manifest. Treatment is uniformly described as symptomatic and supportive because no specific antidote is available. Hospital management often requires gastric lavage, and intensive monitoring of vital signs, electrolyte balance, and renal/thyroid function. Patients with pre-existing thyroid disease and neonates are identified as populations with heightened risk of adverse effects from iodine excess.

Advertisements

Therapeutic Uses of Йодинол

What Йодинол Treats: Main Uses and Benefits

Йодинол (Iodinol) is applied across domains where additional symptomatic support is needed for persistent or recurrent infectious conditions on mucosal surfaces. The solution is generally considered relevant for its broad-spectrum antiseptic properties, which may assist with managing infections and supporting a favorable local environment for recovery. It is utilized for easing symptoms associated with conditions like chronic tonsillitis, chronic purulent otitis, and chronic periodontitis.


Key Therapeutic Applications

Йодинол is commonly used across conditions presenting with localized discomfort and acute episodes where the skin barrier is compromised. It is relevant for managing conditions involving established skin lesions, such as trophic and varicose ulcers, and is applied in addressing the microbial contamination risk in minor cuts, scrapes, and Grade I/II burns. This antiseptic support may assist with easing symptom clusters related to inflammation and discharge, helping patients cope more steadily with difficult episodes. This use provides support that helps ease the overall symptom burden in contexts involving inflammatory or irritative processes, contributing to improved day-to-day comfort.


Quick Fact: Relief for Symptoms of Localized Irritation (commonly used for chronic throat, ear, and skin infections).

Regulatory References

  1. DailyMed (NIH) label information on Povidone-Iodine Antiseptic
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Йодинол?

Population eligibility for the use of Йодинол (Iodinol) is determined by specific contraindications and age restrictions, as stated in official regulatory labeling.

Absolute Contraindications

The medicine must not be used in certain populations or conditions:

  • Age: Children under 6 years of age.
  • Hypersensitivity: Individuals with known hypersensitivity to iodine or any components of the solution.
  • Endocrine Status: Patients with diagnosed thyrotoxicosis.
  • Dermatological Conditions: Patients with Herpetiform dermatitis (Duhring's disease).
  • Reproductive Status: Women who are pregnant (especially in the second and third trimesters) or who are breastfeeding (lactation).
  • Local Restriction: Application in the ear when a perforation of the tympanic membrane (eardrum) is present.

Conditional Use

Use is officially categorized as with caution in several groups:

  • Pediatric/Adolescent: Children and adolescents aged 6 to 18 years.
  • Comorbidity: Patients with impaired renal function or chronic heart failure.
Advertisements

What should I know about interactions with other medicines?

The official interaction profile for Йодинол (an elemental iodine complex antiseptic) is structured around principles of chemical incompatibility and the risk associated with cumulative iodine exposure, as documented in regulatory sources.

Prohibited and Restricted Combinations

The regulatory labeling imposes constraints on co-administration with specific medicinal products and procedures. Use is strictly prohibited before and after Radioactive Iodine Therapy and prior to procedures like Radioiodine Scintigraphy or treatment of thyroid carcinoma, establishing mandatory timing separation rules. The antiseptic must not be used concomitantly with other products containing Mercury, Silver, Hydrogen Peroxide, or Taurolidine due to documented risks of chemical incompatibility that may diminish effectiveness.

Pharmacodynamic Interference and Systemic Risk

The product’s function is subject to pharmacodynamic interference. Official documentation notes that co-administration with enzymatic wound treatment preparations results in the weakening of the effects of both substances. Interference is also cautioned with other topical antiseptics and detergents, which should be avoided due to the potential for antagonism or inactivation. Patients receiving systemic Lithium therapy should avoid use due to the risk of additive hypothyroidic effects. A specific interaction caution is noted for populations with pre-existing thyroid diseases, who face a heightened risk of developing iodine-induced thyroid hyperfunction due to iodine absorption.

Advertisements

Mechanism of Action

Chemical Destruction of Microbial Proteins and Nucleic Acids

The mechanism of Йодинол (Iodinol) is rooted in the high oxidative capacity of elemental iodine ( I2), distinguishing it from mechanisms that rely on specific biological recognition. The active iodine rapidly and irreversibly attacks fundamental microbial proteins (especially sulfhydryl ( SH) groups on enzymes), nucleic acids (DNA/RNA), and cell membrane lipids. This multi-target chemical assault causes the immediate denaturation and deactivation of vital microbial systems, leading to rapid cell death and the comprehensive suppression of microbial viability at the application site.


Polymer-Controlled Sustained Release Mechanism

The active iodine is complexed with Polyvinyl Alcohol (PVA), which functions as a hydrophilic carrier. This mechanism creates a dynamic equilibrium that ensures the controlled and sustained release of the active I2 onto the target surface. This delivery system modulates the chemical activity by prolonging the necessary contact time for microbial destruction while simultaneously reducing the chemical reactivity against host tissue associated with high, instantaneous concentrations of pure I2.


Mechanism Constraint by Organic Binding

A key constraint on the mechanism is that the reactive I2 molecule is non-selectively consumed by organic matter (such as blood or pus) present on the surface. This chemical binding effectively removes the active ingredient from the destructive process, leading to a reduction in the effective microbicidal concentration available to target microorganisms.

Advertisements

Dosage and Administration Information

How to Use Йодинол: Administration Guidelines

This section outlines the administration procedure for Йодинол (Iodinol). This information details the required steps for application and the usage limits, and should not be confused with therapeutic advice.


Administration Protocol

The product is for topical administration (applied directly to the affected surface, such as the skin or mucous membranes). The following steps describe the procedural structure for the use of the medicine:

  1. Preparation: The affected area must be cleaned thoroughly before the medicine is applied.
  2. Application: A small amount of the liquid solution is to be applied to the prepared area.
  3. Frequency and Duration: Application should be performed 1 to 3 times daily.
  4. Usage Limit: The total duration of use must not exceed 1 week unless a healthcare professional specifically advises otherwise.
  5. Post-Application: If a sterile bandage is necessary, the medicine must be allowed to dry completely on the treated area before it is covered.

Summary of Administration Rules

Rule Component Instruction
Route Topical
Dosing Apply a small amount
Preparation Clean affected area first
Frequency 1 to 3 times daily
Max Duration Not longer than 1 week (unless advised by doctor)

These guidelines define the required preparatory steps, the correct method for applying the solution, and the maximum time frame for use, establishing a clear, standardized administration protocol.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Йодинол (Iodinol)


Evidence for Use in Chronic Ear and Oropharyngeal Infections

Research has explored the use of iodine-based antiseptic solutions for chronic ear conditions, focusing on adults and children presenting with symptoms like persistent ear discharge. Studies were primarily conducted using Randomized Controlled Trials (RCTs) and comparative designs. Researchers monitored outcomes related to physical discomfort, such as the duration of ear discharge, and evaluated changes in the microbial population found in the ear. Findings describe patterns observed in studies related to how symptoms evolved during the short-term follow-up. Comparative evidence is often lacking, and the certainty remains low for the evidence comparing this approach to standard topical antibiotics.

Evidence for Use in Chronic Skin Lesions and Wound Care

Topical iodine solutions were evaluated in studies exploring outcomes linked to inflammatory or irritative states in the skin, including populations with chronic leg ulcers and other compromised skin barriers. Studies explored short-term changes, measuring the rate of wound area reduction and the appearance of new, healing tissue. Findings describe patterns observed in studies that evaluated the microbial load present on the wound surface. Research highlights measured changes during the study period, with findings related to the level of contamination. Evidence for the specific Iodinol formulation remains limited, as much of the scientific literature involves other, related iodine complexes.

Long-Term Outcomes and Follow-up in Clinical Research

Most available evidence is derived from studies observing responses over defined, short time intervals, particularly for the management of acute episodes. There is currently limited information for long-term outcomes regarding the use of these preparations for chronic conditions. Data show patterns related to symptom changes during the study period, but the effects over multiple years are not well characterized, and research exploring whether this approach influences future flare-ups is limited.

Evidence Gaps and Areas of Research Uncertainty

Overall certainty remains low for several key research questions. A main limitation is that the evidence quality varies across studies, and many reports are older or confined to small populations. Comparative evidence is lacking, and long-term effects are not fully established. Subgroup findings are uncertain, meaning the evidence does not determine whether an individual will respond similarly across all types of chronic infections or wounds.

Key Studies & References

  1. Antiseptics and Disinfectants: Activity, Action, and Resistance (NCBI Book Shelf)
  2. DailyMed (NIH) Label Information for Povidone-Iodine Antiseptic Solution
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Йодинол (FAQ)

Q: Is Йодинол the same thing as regular alcohol iodine solution?

No. According to the official composition, Йодинол is an iodophor, a complex where active iodine is bound to a polymer like Polyvinyl Alcohol (PVA). This specific formulation is designed to provide a more controlled and prolonged release of iodine. This mechanism generally results in less localized irritation and reduced staining compared to simpler iodine solutions, such as those made with alcohol.


Q: What are the primary conditions or uses described in official documents for Йодинол?

The official general purpose of this medicine is for local surface cleansing and hygiene due to its germ-fighting action. Studies and official information indicate that research has explored its specific application in managing chronic infections of the ear and throat (oropharynx), and in the topical treatment of chronic skin lesions and ulcers.


Q: Can Йодинол be used for cleaning minor cuts or skin abrasions?

The medicine is officially indicated for local surface cleansing and hygiene. Administration guidelines require the product to be applied topically to a cleaned affected area. Its purpose is described as local surface cleansing, which is applicable to superficial skin conditions.


Q: Are there specific symptoms that indicate a user might be experiencing an allergic reaction to Йодинол?

Allergic reactions (hypersensitivity) to iodine-containing products are classified in regulatory documents as rare. Documented severe reactions include systemic conditions such as anaphylactic shock. Users may also experience signs of local intolerance at the application site, such as redness or irritation.


Q: Is there a difference in how children and adults respond to Йодинол?

Official safety documentation highlights that newborns and infants are at an increased risk of developing hypothyroidism from iodine uptake. Therefore, the product is contraindicated for children under 6 years of age and its use is recommended with caution for children aged 6 to 18 years.


Q: How long is the active ingredient in Йодинол understood to remain effective on the treated area?

The unique formulation, where iodine is complexed with Polyvinyl Alcohol (PVA), is designed to ensure a controlled and sustained release of the active ingredient. This mechanism prolongs the necessary contact time needed for its germ-fighting effect on the treated area.


Q: What visual changes should a user typically expect to see on the affected area after treatment?

The solution is a blue-violet liquid and will typically temporarily color the application site as part of the process. Redness (erythema) or a burning sensation at the application site are documented in official safety profiles as possible adverse reactions.


Q: Why is Йодинол sometimes referred to as 'blue iodine'?

The product is physically described as a blue-violet liquid in safety documentation. This specific color is characteristic of the elemental iodine complexed with its polymer carrier, which gives rise to its common name, 'blue iodine.'


Q: What general safety information exists regarding accidental ingestion of a small amount of Йодинол?

According to general safety information for iodine-containing products, accidental ingestion can cause symptoms such as nausea, vomiting, diarrhea, and abdominal pain. In such events, official recommendations are to contact a poison control center or emergency medical services.


Q: Will the blue color of the product stain skin or clothing permanently?

Official regulatory rationale states that the iodophor formulation (iodine complexed with a polymer) was developed specifically to reduce the degree of staining on biological and artificial surfaces. This is a key difference compared to simple iodine solutions.


Q: Is Йодинол safe for older adults to use?

Official documentation indicates that the elderly population, particularly those with pre-existing thyroid conditions, may be at an increased risk of developing iodine-induced hyperfunction (thyrotoxicosis) due to iodine absorption. The potential for this increased risk is highlighted as a specific safety constraint in official documentation.


Q: Does Йодинол interact with any common over-the-counter pain relievers?

The official interaction profile focuses on chemical incompatibilities (such as mercury-containing products) and systemic risks (such as Lithium). General over-the-counter pain relievers are not typically highlighted as a major chemical or systemic interaction risk with topical iodine complexes.


Q: Is it okay to use this product if I am taking blood thinning medicines?

Regulatory warnings for iodine generally caution against use with anticoagulants (blood thinning medicines) due to the potential for systemic effects on clotting factors. However, this concern is primarily linked to iodine absorption, which is generally limited with correct topical application.

Advertisements

How should Йодинол be stored and disposed of?

How to Store and Dispose of Iodinol (Йодинол): Official Requirements

Iodinol must be stored according to strict regulatory guidelines to maintain its quality and ensure safety. Official labeling mandates storage within a temperature range, typically not exceeding 25 C to 30 C, and requires protection from light and moisture. The solution must remain in its original, closed container to preserve the 3-year shelf life.

Official Storage and Disposal Summary

Requirement Area Labeled Mandate
Temperature and Light Store in a dry place, protected from direct sunlight, and below 25 C (or 30 C).
Safety and Access Keep strictly out of the sight and reach of children and unauthorized persons.
Disposal Dispose of unused or expired product and its container in accordance with local regulations.
Environmental Protection Prevent contamination by keeping the product away from drains, surface water, and ground water.

Use of the product after its official expiration date is prohibited.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Йодинол found in:

A-Z Index: